Cepheid-Strategic SWOT Analysis Review

Cepheid-Strategic SWOT Analysis Review

  • Products Id :- GDME7437SA
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cepheid-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.


Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, and oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products directly and also through a network of distributors across Americas, Asia, Europe, Africa and the Middle East regions. The company has partnership with small and large biopharmaceutical companies to develop therapies in anti-infective, critical infectious disease and oncology areas. Cepheid is headquartered in Sunnyvale, California, the US.

Cepheid Key Recent Developments

Sep 21,2016: SystemOne Launches Russian and Kiswahili Versions of GxAlert

Sep 15,2016: Cepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market

Jul 28,2016: Cepheid Reports Second Quarter 2016 Results

Jul 05,2016: Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services

Apr 28,2016: Cepheid Reports First Quarter 2016 Results

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Cepheid-Key Facts 5

Cepheid-Key Employees 6

Cepheid-Key Employee Biographies 7

Cepheid-Major Products and Services 8

Cepheid-History 11

Cepheid-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 17

Cepheid-Business Description 17

Cepheid-SWOT Analysis 18

SWOT Analysis-Overview 18

Cepheid-Strengths 18

Cepheid-Weaknesses 19

Cepheid-Opportunities 20

Cepheid-Threats 21

Cepheid-Key Competitors 22

Section 3-Company's Lifesciences Financial Deals and Alliances 23

Cepheid, Medical Equipment, Deals By Year, 2011 to YTD 2017 23

Cepheid, Medical Equipment, Deals By Type, 2011 to YTD 2017 24

Cepheid, Recent Deals Summary 25

Section 4-Company's Recent Developments 26

Sep 21, 2016: SystemOne Launches Russian and Kiswahili Versions of GxAlert 26

Sep 15, 2016: Cepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market 27

Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results 28

Jul 05, 2016: Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services 29

Apr 28, 2016: Cepheid Reports First Quarter 2016 Results 30

Apr 21, 2016: Cepheid Announces Partner Distribution Agreement With Medline 31

Mar 09, 2016: Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs' 32

Feb 10, 2016: Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations 33

Feb 02, 2016: Cepheid Reports Fourth Quarter And Full Year 2015 Results 34

Jan 07, 2016: USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis 35

Section 5-Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Cepheid, Medical Equipment, Deals By Year, 2011 to YTD 2017 23

Cepheid, Medical Equipment, Deals by Type, 2011 to YTD 2017 24

List of Tables

Cepheid, Key Facts 5

Cepheid, Key Employees 6

Cepheid, Key Employee Biographies 7

Cepheid, Major Products and Services 8

Cepheid, History 11

Cepheid, Subsidiaries 15

Cepheid, Key Competitors 22

Cepheid, Medical Equipment, Deals By Year, 2011 to YTD 2017 23

Cepheid, Medical Equipment, Deals By Type, 2011 to YTD 2017 24

Cepheid, Recent Deals Summary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Cepheid, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com